A
ACXP
Acurx Pharmaceuticals, Inc. Common Stock
$1.15
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Acurx Pharmaceuticals, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$3.10
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.38
Nov 10
Posts
No posts about ACXP yet.
About Acurx Pharmaceuticals, Inc. Common Stock
Acurx Pharmaceuticals is a small clinical-stage biotech company. It develops antibiotics aimed at hard-to-treat bacterial infections, including C. difficile, a gut infection that often comes back after treatment. The company has no products on the market and no sales. It funds its research by selling shares to investors.